Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR217 host gene (MIR217HG), also known as MIR216AHG or MIR216BHG, is a long non-coding RNA gene located on chromosome 2 that acts as the host gene for microRNAs miR-217, miR-216a, and miR-216b[3]. The MIR217HG gene contains multiple transcript variants and does not encode a protein but serves as the genomic locus for these miRNAs. The mature microRNA processed from the gene, miR-217, has been implicated in diverse biological pathways, including cell fate decisions during endoplasmic reticulum stress (via PERK, ATF4, and CHOP signaling), apoptosis, cell proliferation, and matrix remodeling[1][4]. The MIR217HG/miR-217/miR-216a/miR-216b cluster plays roles in many diseases, particularly various cancers and intervertebral disc degeneration, through regulation of target genes and cellular phenotypes. However, MIR217HG itself is not a direct therapeutic target (e.g., like a receptor or enzyme), but a non-coding RNA gene relevant as the host locus for regulatory microRNAs[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR217 host gene (MIR217HG).